Study setting, patients, and treatments
Epilepsy
EPILEPSY
This study was carried out based on a prospective registry of consecutive patients with CSE in the neurological intensive care unit (neuro‐ICU), Department of Neurology, Xijing Hospital, from March 2008 to June 2020. Informed consent was obtained from the patients or their guardians. The procedures of this study were approved by the ethics committee of Xijing Hospital, Fourth Military Medical University (KY20182024‐F‐1) and adhered to the Helsinki Declaration. The study followed the Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis of Diagnosis (TRIPOD) reporting guideline for prognostic studies.Patients who were older than 12 years and fulfilled the International League Against Epilepsy's definition of CSE were enrolled for this study.